The present invention relates to 14- or 15-membered macrolides substituted at the 4'' position of formula (I) ##STR00001## and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.